Member Info for themuir01

https://avacta.wistia.com/medias/1le059gc0v

This is it!!!!

Was mentioned in a video last week... 2 weeks.. did you see the video posted this morning?

Ahh cool.. that was also mentioned for labs too?

https://www.gelifesciences.com/en/us/news-center/reagent-for-covid-19-detection-10001

https://www.gelifesciences.com/en/us/news-center/purification-of-dna-rna-viruses-and-bacteria-10001

The kit is ready....

Hope I'm not barking up the wrong tree here

SeraSil-Mag Virus/Pathogen Kit gives efficient total nucleic acid (DNA/RNA) recovery from different sample types and in different concentrations with high sensitivity in downstream detection. The kit provides a simple and rapid method to address the needs of kit developers and assay designers looking to optimize their workflow for sensitive detection system for viruses and other pathogens found in low concentrations. Our data suggests that this kit and also the RNAspin Mini Kit can help address the demand for a universal extraction kit which copurifies both DNA and RNA or just RNA and can help address the current challenges faced with supplying kits for COVID-19 testing.

Avacta are the kit developer...

Not be long!

Amazing JSP... thanks to Myles!

Milcait when you DYOR you'll find GE Healthcare assist with approvals... that's our partner too

Hi Enzo... sell up and run for the hills

yes he is

Ahh!

If the volume picks up though its worth a cheeky 10 % trade

Yeah good idea

Puke

??

Mikey can you remember when I moaning about Volume at AA.... then come across... SHI might another of those.. I'm not there but it's being ramped...key an eye on it :-)

Degsy $Dollars$ how you doing

Mike.. going to be boring stuck in 1 share.... but we'll be rich! rich I tell thee (",)

LJP1 HAHAHA post of the day... dear dear

2 new partnerships... cancer research institute and another to be announced

& then there this!

https://www.lse.co.uk/rns/AVCT/avacta-and-cytiva-collaborate-on-covid-19-rapid-test-iavpuzrqq1cdbs3.html

GLA DYOR

Avacta founded its Therapeutics division in 2015 precisely as a result of being approached by Moderna, a global
leading mRNA company, and the resulting licensing and option agreement that they entered into. Although
Moderna paid an upfront cash sum of $0.50m, the potential for milestone payments amounting to “several tens
of millions of dollars” for each therapeutic Affimer candidate that Moderna licensed, persuaded Avacta of the
commercial opportunity in moving into the therapeutics space

Moderna Therapeutics
Daewoong Pharmaceutical
ADC Therapeutics